ReviewSkin appendage disorders2017
Botulinum Toxin Off-Label Use in Dermatology: A Review.
Review in Skin appendage disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Targeting Nociceptors in Hidradenitis Suppurativa
Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis Suppurativa
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.
- Pooled it
- Efficacy of Botulinum Toxin A for the Management of Melasma: A Split-Face, Randomized Control Study.Journal of cosmetic dermatology · 2025Trial
- Trial
- Comparative study between botulinum toxin and topical steroid in treatment of psoriasis vulgaris.Archives of dermatological research · 2025Article
- Study on botulinum toxin in dermatology from 2000 to 2023: A CiteSpace-based bibliometric analyses.Journal of cosmetic dermatology · 2024Review
- Real-world Implications of Botulinum Neurotoxin A Immunoresistance for Consumers and Aesthetic Practitioners: Insights from ASCEND Multidisciplinary Panel.Plastic and reconstructive surgery. Global open · 2024Article
- IntramuscularDermatology reports · 2024Article
- Article
- Botulinum neurotoxins: Future innovations.Medicine · 2023Article
- Review
- How Does Botulinum Toxin Inhibit Itch?Toxins · 2022Review
- Successful Topical Application of Botulinum Toxin After Microneedling Versus Microneedling Alone for the Treatment of Atrophic Post Acne Scars: A Prospective, Split-face, Controlled Study.The Journal of clinical and aesthetic dermatology · 2022Article
- Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis.Medicina (Kaunas, Lithuania) · 2022Review
- Review
- Novel Anatomical Guidelines on Botulinum Neurotoxin Injection for Wrinkles in the Nose Region.Toxins · 2022Review
- Hyperhidrosis: disease aetiology, classification and management in the light of modern treatment modalities.Postepy dermatologii i alergologii · 2022Review
- Clinical Observation of Botulinum Toxin Injection in the Treatment of Focal Dystonia and Muscle Spasm.BioMed research international · 2022Article
- [Clinical application and mechanism of botulinum toxin type A in scar treatment].Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns · 2021Article
- Distinctions in the Management, Patient Impact, and Clinical Profiles of Pachyonychia Congenita Subtypes.Skin appendage disorders · 2021Article
- Evaluation of Botulinum Toxin Type A Injection in the Treatment of Localized Chronic Pruritus.The Journal of clinical and aesthetic dermatology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBotulinum toxin is a neurotoxin produced by the bacterium
objectiveTo review and analyze the possible botulinum toxin off-label applications published.
methodsA retrospective review of the published data was conducted.
conclusionsthis potent drug can lead to several off-label indications of interest for dermatologists. Further clinical trials are still needed to better understand the real efficacy and safety of these applications and to standardize injection and dose protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.